Connect your AI

CareDx CDNA Marketable Securities, Accumulated Unrecognized Holding Loss, Short Term

Other financials

Income statement

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept cdna:MarketableSecuritiesAccumulatedUnrecognizedHoldingLossShortTerm.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's marketable securities, accumulated unrecognized holding loss, short term.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CareDx's marketable securities, accumulated unrecognized holding loss, short term?: CareDx (CDNA) reported marketable securities, accumulated unrecognized holding loss, short term of $147K in Q1 2026.